Edward Sargent
Internal Medicine · San Antonio, TXNPI 1609878529
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 146 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $957 and has fallen 97.1% since, to $28 in 2022.
Across 146 payments — averaging $13.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$401
- Novo Nordisk$209
- Amgen$209
- AstraZeneca$209
- AbbVie$183
- Lilly USA, LLC$142
- plus $649 from 21 others
What the payments were for
- Food & beverage$2,002100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 24 | $401 |
| Novo Nordisk | 14 | $209 |
| Amgen | 14 | $209 |
| AstraZeneca | 14 | $209 |
| AbbVie(2 entities) | 9 | $183 |
| Lilly USA, LLC | 32 | $142 |
| Boehringer Ingelheim | 8 | $136 |
| Daiichi Sankyo Inc. | 4 | $72 |
| Astellas Pharma US Inc | 4 | $68 |
| Amarin Pharma, Inc. | 3 | $56 |
| Boston Scientific | 1 | $37 |
| Pharmacosmos Therapeutics Inc. | 2 | $31 |
| Bayer | 2 | $27 |
| Nalpropion Pharmaceuticals LLC | 2 | $26 |
| Intuitive Surgical | 1 | $23 |
| Nevro Corp. | 1 | $19 |
| Dova Pharmaceuticals | 1 | $17 |
| Vertiflex, Inc. | 1 | $16 |
| Novartis | 1 | $15 |
| Merck | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
| Medtronic | 1 | $14 |
| GSK | 1 | $13 |
| Pfizer | 1 | $12 |
| Vistapharm, Inc. | 1 | $12 |
| Eisai Inc. | 1 | $11 |
How this compares
$2,002 in reported general payments places this provider in the 75th percentile of 7,675 internal medicine providers in Texas.
Other internal medicine in San Antonio
- Manuel RodriguezSan Antonio$263K
- Matthew CatesSan Antonio$248K
- Fabian Rodas OchoaSan Antonio$68K
- Darius BuzenasSan Antonio$49K
- Spencer BerthelsenSugar Land$891K
- Hameed AliTemple$773K
- Marc TribbleDallas$693K
- Gary SinclairDallas$599K
- Mohammed Al-NajjarEl Paso$586K
- Han SchmidlyDallas$465K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.